Skip to main content
. 2021 Jun 1;26(6):601–610. doi: 10.1177/10742484211019657

Table 4.

Association Between Safety-Relevant Prescribing Errors and the Use of Amiodarone With DOACs and Major Bleeding.

Variable Crude OR (95%CI) P-value Adjusted ORa (95%CI) P-value
Type of DOAC Apixaban 1 (Ref) 1 (Ref)
Rivaroxaban 2.45 (1.16-5.15) 0.02 2.31 (1.07-5.01) 0.03
Dabigatran 0.84 (0.27-2.57) 0.76 0.84 (0.27-2.87) 0.84
Concomitant use of Amiodarone 1.85 (0.95-3.61) 0.07 1.70 (0.87-3.32) 0.12
Safety-relevant prescribing errors with DOACs 2.17 (1.15-4.08) 0.02 2.17 (1.14-4.12) 0.02

Abbreviations: DOAC, direct oral anticoagulant; Ref, reference.

a  Adjusted for age, sex, type of DOAC and concomitant use of amiodarone.